September 21, 2017
Epigenomics Initiates €5.5M Private Placement Sep 21, 2017, NEW YORK (GenomeWeb) – Epigenomics said today that it plans to raise approximately €5.5 million ($6.5 million) in a […]
September 12, 2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics – Broad collaboration to develop a targeted Next-Generation Sequencing assay for microbial infections – Workflow for native samples […]
August 31, 2017
BERLIN, and GERMANTOWN, Md., Aug. 30, 2017 /PRNewswire/ — Epigenomics AG (Frankfurt Prime Standard: ECX) (OTCQX: EPGNY), today announced the initiation of a Post Approval Study […]
August 15, 2017
– Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches with Biotest’s Pentaglobin® in peritonitis patients – Curetis to provide testing services for […]
August 11, 2017
BioreclamationIVT has acquired Asterand Bioscience™, a global provider of human tissue and research solutions with a focus on the oncology market. Asterand Bioscience advances drug research […]
July 11, 2017
Asterand Bioscience Expands Immuno-oncology Services Capabilities with Vectra Polaris Imaging System
DETROIT & ROYSTON, U.K., July 11, 2017 /EINPresswire.com/ — Asterand Bioscience, the leader in high quality, well-characterized human tissue and human tissue-based research solutions supporting drug discovery […]
May 24, 2017
Curetis Provides Update on Unyvero LRT FDA 510(k) Submission – Curetis reiterates that it expects FDA to provide decision on clearance of Unyvero LRT in the […]
April 28, 2017
Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits – Several ECCMID 2017 presentations highlight advantages of rapid time to result […]
April 26, 2017
Epigenomics Agrees to Takeover Bid Apr 26, 2017 NEW YORK (GenomeWeb) – German molecular diagnostics firm Epigenomics announced today that it has agreed to a public […]
